Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antiviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Large-scale testing (Phase 3)Study completedNCT01641640
What this trial is testing

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 328
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Not applicableStudy completedNCT02824640
What this trial is testing

Patient-Centered Models of HCV Care for People Who Inject Drugs

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 755
Testing effectiveness (Phase 2)Ended earlyNCT02613403
What this trial is testing

Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)

Who this might be right for
HepatitisHepatitis CDigestive System Diseases+5 more
Merck Sharp & Dohme LLC 94
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Not applicableStudy completedNCT03707080
What this trial is testing

Direct Acting Antiviral-Post Authorization Safety Study

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Target PharmaSolutions, Inc. 42
Post-approval studies (Phase 4)Study completedNCT02156570
What this trial is testing

DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)

Who this might be right for
Hepatitis C
Kirby Institute 20
Not applicableStudy completedNCT04159545
What this trial is testing

Future Destinations: Journeys Towards Citizenship

Who this might be right for
Hepatitis CDrug Use
University of Dundee 15
Large-scale testing (Phase 3)UnknownNCT02985281
What this trial is testing

Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients

Who this might be right for
Pharmacological Action
National Liver Institute, Egypt 41
Not applicableEnded earlyNCT02510300
What this trial is testing

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 461